News

Researchers at the Netherlands Institute for Neuroscience discovered why you will be better able to bear tomorrow what you are distressed about today if you have a night of solid REM sleep.

More than half of the drugs that have entered the market in Germany since then have emerged from these assessments without any proven added benefit. In a new publication using the first 216 assessments, researchers examine the reasons for this sobering result and develop suggestions for improvements in drug development.

A team has found that the gene "mEAK-7" may play a significant role in cancer metastasis, at least in lung cancers.

A mouse study has suggested that an injection of nanoparticles can prevent the body's immune system from overreacting to trauma, potentially preventing some spinal cord injuries from resulting in paralysis.

An epigenetic change that deactivates some genes linked to cancer late in human development has been conserved for more than 400 million years, new research suggests.

A research team has identified an enzyme involved in remodeling the plasma membrane of multiple types of cancer cell, that is critical to both survival of tumors and uncontrolled growth.

Researchers have published research connecting an enzyme associated with detoxification to obesity and fatty liver disease, especially in males.

Africa has new purple-clad warriors more than 200 feet beneath the ocean’s surface. Deep-diving scientists spotted dazzling fairy wrasses—previously unknown to science—in the dimly lit mesophotic coral reefs of eastern Zanzibar, off the coast of Tanzania.

Researchers at ETH Zurich have developed a technique for embedding data in music and transmitting it to a smartphone. Since the data is imperceptible to the human ear, it doesn’t affect listening pleasure. This could have interesting applications in hotels, museums and department stores.

A comprehensive, longitudinal study of patients with multiple sclerosis (MS) that followed patients from the time of their diagnosis for an average of five years, has found that while a commonly used imaging linear contrast agent, gadodiamide, does accumulate in the brain early in the disease, there is no discernible clinical impact.